Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-FR Version v1-EN
Language French English
Date Updated 2018-10-22 2018-10-22
Drug Identification Number 02376520 02376520
Brand name ACT CANDESARTAN ACT CANDESARTAN
Common or Proper name CANDESARTAN CANDESARTAN
Company Name ACTAVIS PHARMA COMPANY ACTAVIS PHARMA COMPANY
Ingredients CANDESARTAN CILEXETIL CANDESARTAN CILEXETIL
Strength(s) 4MG 4MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100 100
ATC code C09CA C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date
Actual discontinuation date 2018-03-30 2018-03-30
Remaining supply date 2018-03-30 2018-03-30
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Information on remaining supply
Company comments Transitioned. TEVA available
Health Canada comments